SK9793A3 - Pharmaceutical dosing form with extended release of active substance - Google Patents

Pharmaceutical dosing form with extended release of active substance Download PDF

Info

Publication number
SK9793A3
SK9793A3 SK9793A SK9793A SK9793A3 SK 9793 A3 SK9793 A3 SK 9793A3 SK 9793 A SK9793 A SK 9793A SK 9793 A SK9793 A SK 9793A SK 9793 A3 SK9793 A3 SK 9793A3
Authority
SK
Slovakia
Prior art keywords
release
pharmaceutical dosage
dosage form
nifedipine
hours
Prior art date
Application number
SK9793A
Other languages
English (en)
Slovak (sk)
Inventor
Sabine Compassi
Original Assignee
Siegfried Ag Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Ag Pharma filed Critical Siegfried Ag Pharma
Publication of SK9793A3 publication Critical patent/SK9793A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
SK9793A 1992-02-17 1993-02-17 Pharmaceutical dosing form with extended release of active substance SK9793A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH46492 1992-02-17

Publications (1)

Publication Number Publication Date
SK9793A3 true SK9793A3 (en) 1993-09-09

Family

ID=4187618

Family Applications (1)

Application Number Title Priority Date Filing Date
SK9793A SK9793A3 (en) 1992-02-17 1993-02-17 Pharmaceutical dosing form with extended release of active substance

Country Status (12)

Country Link
US (1) US5439687A (ru)
JP (1) JPH061716A (ru)
CA (1) CA2086989A1 (ru)
CZ (1) CZ285177B6 (ru)
FI (1) FI930657A (ru)
HU (1) HU222252B1 (ru)
IL (1) IL104192A (ru)
MX (1) MX9300664A (ru)
NO (1) NO302216B1 (ru)
PL (1) PL172361B1 (ru)
RU (1) RU2122413C1 (ru)
SK (1) SK9793A3 (ru)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
JP2676319B2 (ja) * 1994-02-09 1997-11-12 大洋薬品工業株式会社 塩酸ニカルジピンの徐放剤用製剤およびこれを利用した徐放化製剤
MX9801835A (es) * 1996-07-08 1998-08-30 Mendell Co Inc Edward Matriz de liberacion sostenida para medicamentos insolubles de dosis altas.
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
CA2216215A1 (en) 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
HUP0104472A3 (en) 1999-09-30 2002-12-28 Penwest Pharmaceuticals Co Pat Sustained release matrix systems for highly soluble drugs
KR100379299B1 (ko) * 2000-01-15 2003-04-10 주식회사 중외제약 펠로디핀의 가용화 방법 및 방출제어형 제제
US20030180354A1 (en) * 2001-10-17 2003-09-25 Dr. Reddy's Laboratories Limited Amlodipine maleate formulations
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
BE1014922A3 (nl) * 2002-03-01 2004-06-01 Pfizer Ltd Amlodipine als vrije base.
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
ATE408400T1 (de) * 2002-05-21 2008-10-15 Watson Lab Inc Pharmazeutische zusammensetzung mit verzögerter freisetzung
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
AU2003265446A1 (en) * 2002-08-13 2004-02-25 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
ATE437634T1 (de) * 2004-01-14 2009-08-15 Lavipharm Lab Inc Transdermale abgabevorrichtung für dihydropyridin-artige calcium-antagonisten mit 2 fettsäuren
CA2568378C (en) * 2004-05-28 2013-03-19 Abbott Gmbh & Co. Kg Formulation obtained from a powder mixture comprising an inorganic pigment
US20060210623A1 (en) * 2005-03-17 2006-09-21 Stach Paul E Sustained release delivery of isradipine
US20070128282A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
US20070128280A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
US20080057123A1 (en) 2006-08-30 2008-03-06 Jagotec Ag Controlled Release Formulations
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
CA2677053C (en) * 2007-01-31 2016-03-15 Methylation Sciences International Srl Extended release pharmaceutical formulations of s-adenosylmethionine
JP4864024B2 (ja) * 2008-02-15 2012-01-25 エスエス製薬株式会社 時限放出製剤
KR20100069170A (ko) * 2008-12-16 2010-06-24 삼일제약주식회사 라시디핀 함유 과립 및 이를 포함하는 약학 조성물
KR101136075B1 (ko) * 2009-06-30 2012-04-17 케이엘피앤지씨앤팜 주식회사 고혈압 치료제 조성물
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
PL389530A1 (pl) 2009-11-10 2011-05-23 Fabryka Maszyn FAMUR Spółka Akcyjna Sposób przeniesienia napędu w kombajnie górniczym ścianowym
WO2019004448A1 (ja) * 2017-06-30 2019-01-03 興和株式会社 医薬組成物
CN112592311B (zh) * 2021-01-03 2023-01-31 迪沙药业集团有限公司 一种硝苯地平a晶块状晶习及其控释片组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
SI8810082A8 (en) * 1988-01-18 1995-12-31 Lek Tovarna Farmacevtskih Process for preparing new inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrine
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
US4893393A (en) * 1988-10-25 1990-01-16 Marshall Ben C Pipe fitting assembly tool

Also Published As

Publication number Publication date
FI930657A0 (fi) 1993-02-15
IL104192A0 (en) 1993-05-13
HU9300424D0 (en) 1993-05-28
CA2086989A1 (en) 1993-08-18
PL297747A1 (en) 1993-11-02
HUT64694A (en) 1994-02-28
RU2122413C1 (ru) 1998-11-27
JPH061716A (ja) 1994-01-11
US5439687A (en) 1995-08-08
NO302216B1 (no) 1998-02-09
CZ8193A3 (en) 1994-01-19
HU222252B1 (hu) 2003-05-28
NO930543L (no) 1993-08-18
NO930543D0 (no) 1993-02-16
PL172361B1 (pl) 1997-09-30
IL104192A (en) 1998-01-04
MX9300664A (es) 1994-07-29
FI930657A (fi) 1993-08-18
CZ285177B6 (cs) 1999-06-16

Similar Documents

Publication Publication Date Title
SK9793A3 (en) Pharmaceutical dosing form with extended release of active substance
CA2432178C (en) Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles
US6811794B2 (en) Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
JP5783489B2 (ja) トロスピウムの１日１回剤形
US9040086B2 (en) Timed, sustained release systems for propranolol
US6110494A (en) Cisapride mini-tablet formulations
US20060222709A1 (en) Metformin methods and formulations for treating chronic constipation
AU2002249881A1 (en) Sustained release pharmaceutical dosage forms with minimized PH dependent dissolution profiles
NZ537410A (en) Extended release formulations of clarithromycin that minimise adverse effects and provide at least equivalent to tablet or liquid formulations
KR20090065520A (ko) 코어 및 하나 이상의 배리어 층을 포함하는 방출 제어형 경구 투여 제제
KR20010086062A (ko) 고가용성 약물용 서방성 메트리스 시스템
US6531151B1 (en) Composition containing hydroxypropylmethylcellulose and/or ethylcellulose as disintegrants and process for producing it
JP2005508901A (ja) 活性成分を徐放する剤形
NZ539192A (en) Sustained release composition for oral administration of drugs
AU782059B2 (en) Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
EP0557244B1 (en) Dosage forms having prolonged active-ingredient release
US20080260785A1 (en) Paroxetine compositions
AU2006335344A1 (en) Controlled release formulation of divalproic acid and its derivatives
TW201609196A (zh) 控制釋放製劑及其製備方法
TR2023000985A2 (tr) Kontrollü salim sağlayan propi̇veri̇n formülasyonu
WO2008038106A1 (en) Venlafaxine extended release formulations
JP2005510449A (ja) 改良型制御放出経口剤形
EP0951905A2 (en) Pharmaceutical compositions for programmed therapeutical coverage